AR034621A1 - Formulaciones - Google Patents
FormulacionesInfo
- Publication number
- AR034621A1 AR034621A1 ARP020102369A ARP020102369A AR034621A1 AR 034621 A1 AR034621 A1 AR 034621A1 AR P020102369 A ARP020102369 A AR P020102369A AR P020102369 A ARP020102369 A AR P020102369A AR 034621 A1 AR034621 A1 AR 034621A1
- Authority
- AR
- Argentina
- Prior art keywords
- refers
- formulations
- oxothioxanten
- diethylamino
- formamide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente se refiere a una formulación de N-[[1-[[2-(dietilamino)etil]amino]-7-metoxi-9-oxotioxanten-4-il]metil]formamida o una sal de adición de ácido farmacéuticamente aceptable de la misma, y se refiere al método de utilización de la misma en el tratamiento de tumores y cánceres.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0115893.0A GB0115893D0 (en) | 2001-06-28 | 2001-06-28 | Formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
AR034621A1 true AR034621A1 (es) | 2004-03-03 |
Family
ID=9917582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP020102369A AR034621A1 (es) | 2001-06-28 | 2002-06-24 | Formulaciones |
Country Status (22)
Country | Link |
---|---|
US (1) | US20050176619A1 (es) |
EP (1) | EP1406699A1 (es) |
JP (1) | JP2004536099A (es) |
KR (1) | KR20040030709A (es) |
CN (1) | CN1520325A (es) |
AR (1) | AR034621A1 (es) |
BG (1) | BG108459A (es) |
BR (1) | BR0210671A (es) |
CA (1) | CA2451195A1 (es) |
CZ (1) | CZ20033434A3 (es) |
EE (1) | EE200400041A (es) |
GB (1) | GB0115893D0 (es) |
HR (1) | HRP20031048A2 (es) |
HU (1) | HUP0402039A2 (es) |
IL (1) | IL159206A0 (es) |
IS (1) | IS7070A (es) |
MX (1) | MXPA03012064A (es) |
NO (1) | NO20035668D0 (es) |
PL (1) | PL367636A1 (es) |
RU (1) | RU2003136086A (es) |
SK (1) | SK15492003A3 (es) |
WO (1) | WO2003002202A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2503719T3 (es) * | 2005-02-11 | 2014-10-07 | Immunogen, Inc. | Procedimiento para preparar conjugados de anticuerpos y de maitansinoides |
CA2892010A1 (en) * | 2012-11-20 | 2014-05-30 | Vita Naturale, Llc | Compositions and methods for their dermatological use |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5346917A (en) * | 1991-06-10 | 1994-09-13 | Sterling Winthrop Inc. | Thioxanthenone antitumor agents |
US5665760A (en) * | 1995-09-18 | 1997-09-09 | Sanofi Winthrop, Inc. | Lyophilized thioxanthenone antitumor agents |
US20030022920A1 (en) * | 2001-06-19 | 2003-01-30 | Christoph Ullmer | 1-Methyl-4- (3-ethoxy-9H-thioxanthene-9-ylidene) -piperidine and its use as 5-HT2B/H1 receptor antagonist |
-
2001
- 2001-06-28 GB GBGB0115893.0A patent/GB0115893D0/en not_active Ceased
-
2002
- 2002-06-24 AR ARP020102369A patent/AR034621A1/es not_active Application Discontinuation
- 2002-06-28 SK SK1549-2003A patent/SK15492003A3/sk unknown
- 2002-06-28 US US10/480,692 patent/US20050176619A1/en not_active Abandoned
- 2002-06-28 JP JP2003508438A patent/JP2004536099A/ja active Pending
- 2002-06-28 IL IL15920602A patent/IL159206A0/xx unknown
- 2002-06-28 HU HU0402039A patent/HUP0402039A2/hu unknown
- 2002-06-28 WO PCT/GB2002/003012 patent/WO2003002202A1/en not_active Application Discontinuation
- 2002-06-28 EP EP02748985A patent/EP1406699A1/en not_active Withdrawn
- 2002-06-28 MX MXPA03012064A patent/MXPA03012064A/es not_active Application Discontinuation
- 2002-06-28 EE EEP200400041A patent/EE200400041A/xx unknown
- 2002-06-28 CZ CZ20033434A patent/CZ20033434A3/cs unknown
- 2002-06-28 CN CNA028127552A patent/CN1520325A/zh active Pending
- 2002-06-28 RU RU2003136086/15A patent/RU2003136086A/ru not_active Application Discontinuation
- 2002-06-28 KR KR10-2003-7016976A patent/KR20040030709A/ko not_active Application Discontinuation
- 2002-06-28 CA CA002451195A patent/CA2451195A1/en not_active Abandoned
- 2002-06-28 PL PL02367636A patent/PL367636A1/xx not_active Application Discontinuation
- 2002-06-28 BR BR0210671-0A patent/BR0210671A/pt not_active IP Right Cessation
-
2003
- 2003-12-11 IS IS7070A patent/IS7070A/is unknown
- 2003-12-16 BG BG108459A patent/BG108459A/xx unknown
- 2003-12-17 HR HR20031048A patent/HRP20031048A2/xx not_active Application Discontinuation
- 2003-12-18 NO NO20035668A patent/NO20035668D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EE200400041A (et) | 2004-04-15 |
JP2004536099A (ja) | 2004-12-02 |
MXPA03012064A (es) | 2004-03-26 |
BG108459A (en) | 2005-02-28 |
HRP20031048A2 (en) | 2004-04-30 |
CZ20033434A3 (cs) | 2004-08-18 |
IS7070A (is) | 2003-12-11 |
EP1406699A1 (en) | 2004-04-14 |
PL367636A1 (en) | 2005-03-07 |
GB0115893D0 (en) | 2001-08-22 |
BR0210671A (pt) | 2004-10-13 |
RU2003136086A (ru) | 2005-05-27 |
HUP0402039A2 (hu) | 2005-01-28 |
KR20040030709A (ko) | 2004-04-09 |
US20050176619A1 (en) | 2005-08-11 |
CN1520325A (zh) | 2004-08-11 |
CA2451195A1 (en) | 2003-01-09 |
WO2003002202A1 (en) | 2003-01-09 |
NO20035668D0 (no) | 2003-12-18 |
SK15492003A3 (sk) | 2004-06-08 |
IL159206A0 (en) | 2004-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1108874T1 (el) | ΧΡΗΣΗ ΤΩΝ ΑΝΑΣΤΟΛΕΩΝ Ι κΒ- ΚΙΝΑΣΗΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΠΟΝΟΥ | |
GEP20063777B (en) | Crystals Including Malic Acid Salt of N-[2-(Diethylamino) Ethyl]-5-[(5-Fluoro-2-Oxo-3h-Indole-3-Ylidene) Methyl]-2, 4-Dimethyl-1h-Pyrrole-3-Carboxamide, Processes for Its Preparation and Compositions Thereof | |
ATE411022T1 (de) | Pyridylpyrrol-derivate als wirksame kinase-hemmer | |
EA200501849A1 (ru) | Производные пиразолохиназолина: способ получения и применение в качестве ингибиторов киназ | |
ATE400573T1 (de) | 1h-imidazochinolinderivate als proteinkinaseinhibitoren | |
CY2009002I2 (el) | Χρηση αμινοξικων αντισπασμωδικων για τη θεραπευτικη αγωγη του πονου | |
DE60323090D1 (de) | 1h-imidazoä4,5-cüchinolinderivate zur behandlung von protein kinase-abhängigen krankheiten | |
ATE468332T1 (de) | Phenyl-(4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin- - yi)aminderivate | |
BR0212042A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto | |
ECSP055701A (es) | Nuevos derivados de pirimidinamida y el uso de los mismos | |
CY1110906T1 (el) | Φαρμακευτικη συνθεση για ρινικη χορηγηση φεντανυλης | |
GEP20074123B (en) | Amino acids with affinity for the alpha−2−delta−protein | |
AU2001235006A1 (en) | Prophylactic and therapeutic monoclonal antibodies | |
MXPA03010054A (es) | Composiciones que comprenden lopinavir y metodos para aumentar la biodisponibilidad de agentes farmaceuticos. | |
SE0102440D0 (sv) | New compound | |
CY1109001T1 (el) | Οι καππα-οπιοιδεις αγωνιστες στη θεραπεια των παθησεων της κυστης | |
IT1319210B1 (it) | Pellicola per la somministrazione dermica e transdermica di principiattivi. | |
NO20051261L (no) | Morfin-6-glukuronidsalt | |
FR2880023B1 (fr) | Derives de n-[(4,5-diphenyl-3-alkyl-2-thienyl) methyl] amine leur preparation et leur application en therapeutique | |
EE05241B1 (et) | Distamtsiini a-halogenoakrlolderivaadi kasutamine | |
SE0001916D0 (sv) | Novel formulation | |
NO20041378L (no) | [[2-(Amino-3,4-diokso-1-cyklobuten-1-yl)amino]alkyl]-syrederivater for behandling av smerte | |
AR034621A1 (es) | Formulaciones | |
FR2842527B1 (fr) | Derives d'acyloxypyrolidine, leur preparation et leur application en therapeutique | |
WO2004073627A3 (en) | Novel therapeutic method and compositions for topical administration |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |